Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation

NCT00402532 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT00402532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
Lead sponsor
Hannover Medical School
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
December 31, 2011
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplantation